— Know what they know.
Not Investment Advice

ALT NASDAQ

Altimmune, Inc.
1W: +0.3% 1M: -15.6% 3M: -33.1% YTD: -37.5% 1Y: -36.7% 3Y: -29.2% 5Y: -77.3%
$2.90
-0.03 (-1.02%)
 
Weekly Expected Move ±12.0%
$2 $3 $3 $3 $4
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 44 · $255.9M mcap · 88M float · 4.51% daily turnover · Short 35% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
37.6 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: 594.6%
Cost Advantage
28
Intangibles
37
Switching Cost
49
Network Effect
43
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ALT has No discernible competitive edge (37.6/100). The business operates without significant structural advantages. The primary source of advantage is Switching Costs. ROIC of 594.6% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$2
Low
$2
Avg Target
$11
High
Based on 2 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 12Hold: 3Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$2.50
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-24 Goldman Sachs Corinne Johnson $20 $2 -18 -13.5% $2.89
2026-01-27 Barclays Initiated $20 +223.6% $6.18
2024-04-02 H.C. Wainwright Patrick Trucchio $50 $12 -38 +17.3% $10.23
2022-12-01 Goldman Sachs Initiated $20 +101.0% $9.95
2022-11-11 JMP Securities Initiated $26 +133.8% $11.12
2022-08-31 Jefferies Initiated $35 +58.5% $22.08
2022-08-30 Piper Sandler Yasmeen Rahimi Initiated $25 +32.0% $18.94
2022-08-17 H.C. Wainwright Initiated $50 +183.1% $17.66

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
May 22, 2026
DCF
3
ROE
1
ROA
1
D/E
3
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ALT receives an overall rating of C+. Strongest factors: P/B (4/5). Areas of concern: ROE (1/5), ROA (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-18 C C+
2026-05-13 D+ C
2026-05-13 C D+
2026-04-27 C+ C
2026-03-06 C C+
2026-03-05 C+ C
2026-01-12 C C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

Grade A+
Profitability
Balance Sheet
16
Earnings Quality
39
Growth
69
Value
31
Momentum
64
Safety
15
Cash Flow
30

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.96
Distress Zone
Piotroski F-Score
5/9
Beneish M-Score
Ohlson O-Score
-5.94
Bankruptcy prob: 0.3%
Low Risk
Credit Rating
BB-
Score: 37.1/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.79x
Accruals: -9.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ALT scores 0.96, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ALT scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ALT's implied 0.3% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ALT receives an estimated rating of BB- (score: 37.1/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-3.96x
PEG
-0.12x
P/S
7109.62x
P/B
1.27x
P/FCF
-5.33x
P/OCF
EV/EBITDA
-1.56x
EV/Revenue
4043.73x
EV/EBIT
-1.56x
EV/FCF
-2.02x
Earnings Yield
-23.76%
FCF Yield
-18.77%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ALT currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.974
EBT / EBIT
×
EBIT Margin
-2598.278
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
1.203
Assets / Equity
=
ROE
-52.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ALT's ROE of -52.3% is driven by Asset Turnover (0.000), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$2.90
Median 1Y
$1.64
5th Pctile
$0.27
95th Pctile
$10.23
Ann. Volatility
106.8%
Analyst Target
$2.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Vipin K. Garg,
Ph.D. Chief Executive Officer
$658,694 $1,153,600 $8,026,590
M. Scott Harris,
M.D. former Chief Medical Officer
$388,403 $443,800 $2,631,071
Christophe Arbet-Engels, M.D.,
Ph.D.
$128,750 $580,500 $2,329,895
M. Scot Roberts,
Ph.D. Chief Scientific Officer
$487,306 $443,800 $2,182,996

CEO Pay Ratio

16:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $8,026,590
Avg Employee Cost (SGA/emp): $492,947
Employees: 57

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
57
-3.4% YoY
Revenue / Employee
$719
Rev: $41,000
Profit / Employee
$-1,545,491
NI: $-88,093,000
SGA / Employee
$492,947
Avg labor cost proxy
R&D / Employee
$1,165,474
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -50.2% -61.8% -45.7% -47.8% -45.6% -40.9% -44.1% -44.4% -42.3% -40.8% -46.6% -48.9% -53.4% -54.6% -59.9% -56.8% -55.3% -52.8% -50.6% -52.3% -52.29%
ROA -45.5% -56.0% -41.9% -43.8% -41.8% -37.5% -39.8% -40.1% -38.2% -36.9% -42.4% -44.4% -48.5% -49.6% -54.3% -51.6% -50.1% -48.0% -42.0% -43.5% -43.45%
ROIC -4.6% -5.6% -7.4% -7.7% -7.4% -6.8% -45.1% -46.3% -45.0% -43.9% 24.9% 26.2% 28.5% 29.0% 12.2% 11.6% 11.1% 10.7% 5.8% 5.9% 5.95%
ROCE -28.2% -34.7% -42.6% -46.3% -47.9% -43.7% -47.0% -46.3% -45.3% -44.1% -46.5% -48.7% -52.0% -52.1% -73.8% -70.6% -68.4% -65.1% -33.8% -35.3% -35.31%
Gross Margin -95.9% -183.8% -5.4% -526.6% 1.0% -10130.0% 175.4% 1.0% -2207.8% -49.8% 1.0% -20.4% 1.0% 1.0% 1.0% 1.0% 1.0% -2991.0% 1.0%
Operating Margin -181.5% -210.2% -7.3% -609.3% -2549.4% -12376.0% 209.9% -1036.1% -3001.2% -62.3% -908.7% -5358.8% -5349.0% -4953.4% -4973.2% -4363.0% -4584.4% -4171.8% -1111.3%
Net Margin -181.2% -212.1% -7.3% -607.2% -2513.4% -11758.0% 196.9% -955.9% -2676.8% -57.1% -855.2% -4878.8% -4928.0% -4569.0% -4636.0% -3915.0% -4429.2% -3802.8% -1052.2%
EBITDA Margin -122.0% -208.3% -6.5% -661.2% -2498.6% -12370.8% 205.7% -949.9% -2980.3% -61.9% -804.0% -4857.2% -4915.6% -4560.4% -4629.2% -4045.2% -4370.4% -3698.4% -1111.3%
FCF Margin -11.8% -23.8% -20.5% -22.3% -20.2% -20.3% 922.2% 868.8% 882.4% -275.4% -178.5% -177.9% -174.8% -1502.2% -3992.4% -4016.6% -4094.1% -3333.0% -1654.7% -1999.1% -1999.08%
OCF Margin -9.9% -20.2% -17.7% -20.0% -20.1% -20.3% 920.4% 866.7% 880.6% -275.1% -178.4% -177.9% -174.8% -1502.2% -3992.4% -4016.6% -4093.6% -3332.5% -1654.5% -1998.2% -1998.19%
ROE 3Y Avg snapshot only -53.79%
ROE 5Y Avg snapshot only -51.69%
ROA 3Y Avg snapshot only -47.12%
ROIC Economic snapshot only -29.38%
Cash ROA snapshot only -25.70%
NOPAT Margin snapshot only -2126.81%
Pretax Margin snapshot only -2530.03%
R&D / Revenue snapshot only 1854.83%
SGA / Revenue snapshot only 837.69%
SBC / Revenue snapshot only 235.97%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -5.98 -5.58 -3.93 -2.63 -5.73 -7.24 -9.71 -2.48 -2.20 -1.78 -7.43 -7.77 -4.65 -4.22 -5.40 -4.19 -3.59 -4.02 -4.12 -4.21 -3.963
P/S Ratio 65.43 135.79 86.63 74.30 159.94 189.63 -12102.04 -2677.60 -2209.15 499.81 1543.38 1757.95 1153.17 8393.47 25689.55 18886.94 15765.91 16855.30 8858.89 10648.40 7109.616
P/B Ratio 1.80 2.07 1.92 1.34 2.79 3.16 4.44 1.14 0.97 0.75 3.39 3.71 2.43 2.25 4.16 3.06 2.55 2.73 1.62 1.70 1.271
P/FCF -5.53 -5.71 -4.22 -3.34 -7.91 -9.33 -13.12 -3.08 -2.50 -1.81 -8.65 -9.88 -6.60 -5.59 -6.43 -4.70 -3.85 -5.06 -5.35 -5.33 -5.327
P/OCF
EV/EBITDA -2.96 -3.17 -2.27 -0.86 -3.84 -5.05 -7.22 -0.32 0.06 0.53 -5.12 -5.55 -2.72 -2.36 -4.05 -2.73 -2.10 -2.47 -1.40 -1.56 -1.558
EV/Revenue 31.04 73.66 43.82 21.92 105.62 132.76 -9399.75 -351.57 59.44 -158.81 1080.60 1277.12 671.16 4602.24 19179.05 12376.44 9255.41 10344.80 3059.67 4043.73 4043.733
EV/EBIT -2.94 -3.14 -2.26 -0.85 -3.82 -5.03 -7.17 -0.32 0.06 0.53 -4.99 -5.42 -2.66 -2.31 -4.04 -2.72 -2.10 -2.47 -1.40 -1.56 -1.556
EV/FCF -2.62 -3.10 -2.13 -0.98 -5.22 -6.53 -10.19 -0.40 0.07 0.58 -6.05 -7.18 -3.84 -3.06 -4.80 -3.08 -2.26 -3.10 -1.85 -2.02 -2.023
Earnings Yield -16.7% -17.9% -25.4% -38.0% -17.4% -13.8% -10.3% -40.4% -45.4% -56.3% -13.5% -12.9% -21.5% -23.7% -18.5% -23.9% -27.8% -24.9% -24.3% -23.8% -23.76%
FCF Yield -18.1% -17.5% -23.7% -30.0% -12.6% -10.7% -7.6% -32.4% -39.9% -55.1% -11.6% -10.1% -15.2% -17.9% -15.5% -21.3% -26.0% -19.8% -18.7% -18.8% -18.77%
Price/Tangible Book snapshot only 1.705
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 19.16 19.16 11.17 11.17 11.17 11.17 11.31 11.31 11.31 11.31 17.26 17.26 17.26 17.26 13.11 13.11 13.11 13.11 18.55 18.55 18.550
Quick Ratio 19.16 19.16 11.17 11.17 11.17 11.17 11.31 11.31 11.31 11.31 17.26 17.26 17.26 17.26 13.11 13.11 13.11 13.11 18.55 18.55 18.550
Debt/Equity 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.16 0.16 0.159
Net Debt/Equity -0.95 -0.95 -0.95 -0.95 -0.95 -0.95 -0.99 -0.99 -0.99 -0.99 -1.02 -1.02 -1.02 -1.02 -1.05 -1.05 -1.05 -1.05 -1.06 -1.06 -1.057
Debt/Assets 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.13 0.13 0.127
Debt/EBITDA -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.02 -0.02 -0.40 -0.38 -0.382
Net Debt/EBITDA 3.27 2.67 2.22 2.05 1.98 2.16 2.08 2.10 2.16 2.22 2.19 2.09 1.95 1.94 1.37 1.43 1.48 1.56 2.66 2.54 2.544
Interest Coverage -1722.03 -1171.58 -1276.48 -793.35 -600.44 -458.73 -466.84 -671.45 -1263.60 -2536.76 -2635.94 -2840.56 -3127.61 -10351.00 -10561.11 -10101.33 -324.10 -110.16 -54.74 -34.61 -34.605
Equity Multiplier 1.09 1.09 1.10 1.10 1.10 1.10 1.12 1.12 1.12 1.12 1.09 1.09 1.09 1.09 1.13 1.13 1.13 1.13 1.24 1.24 1.245
Cash Ratio snapshot only 18.234
Debt Service Coverage snapshot only -34.576
Cash to Debt snapshot only 7.662
FCF to Debt snapshot only -2.017
Defensive Interval snapshot only 1225.4 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.04 0.02 0.02 0.02 0.01 0.01 -0.00 -0.00 -0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Inventory Turnover
Receivables Turnover (trade) 2.21 1.22 1.75 1.43 1.38 1.32 -0.23 -0.26 -0.27 0.93 0.66 0.64 0.64 0.08 0.02 0.02 0.02 0.02 0.05 0.04 0.041
Payables Turnover 124.58 217.22 56.32 60.77 50.74 43.98 16.47 11.54 15.41 14.86 9.21 9.24 5.38 0.03 0.09 0.00 0.00 13.12 10.22 10.23 10.234
DSO (trade) 165 298 209 255 265 277 -1616 -1391 -1356 394 550 572 573 4506 15102 15102 15102 15102 7848 8937 8937.4 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 3 2 6 6 7 8 22 32 24 25 40 40 68 11724 3890 28 36 36 35.7 days
Cash Conversion Cycle (trade) 162 297 202 249 257 269 369 510 532 505 -7218 11211 15074 7812 8902 8901.8 days
Fixed Asset Turnover snapshot only 0.115
Cash Velocity snapshot only 0.000
Capital Intensity snapshot only 7775.806
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 49.9% -46.6% -46.1% -47.1% -44.2% -3.7% -1.0% -1.0% -1.0% -91.6% 7.3% 6.2% 6.0% -81.4% -95.3% -95.1% -95.1% -61.5% 1.1% 80.0% 80.00%
Net Income -90.8% -97.1% -98.0% -69.4% -42.4% -3.7% 12.7% 16.0% 16.1% 9.7% -4.4% -8.7% -24.6% -31.9% -7.5% 2.7% 13.4% 18.9% 7.3% -0.9% -0.93%
EPS 17.5% -57.5% -84.7% -49.9% -24.0% 12.9% 27.3% 26.3% 21.4% 17.1% 10.6% 23.1% 10.9% 0.5% 11.9% 8.8% 24.6% 35.6% 34.4% 38.7% 38.73%
FCF -3.6% -2.5% -1.6% -48.0% 4.6% 17.7% 30.7% 14.5% -1.7% -13.9% -21.3% -6.3% -0.0% -1.6% -5.0% -10.1% -14.5% 14.7% 15.0% 10.4% 10.41%
EBITDA -71.2% -76.2% -45.2% -37.8% -46.0% -9.0% -4.2% 5.3% 10.8% 5.1% -1.7% -8.0% -18.6% -22.4% -5.4% 3.8% 12.9% 17.5% 5.6% -3.0% -2.98%
Op. Income -66.5% -73.0% -76.9% -62.9% -41.1% -5.9% 9.5% 11.4% 9.8% 3.6% -9.3% -12.2% -25.2% -31.1% -7.6% 2.7% 14.0% 19.2% 8.4% 1.3% 1.30%
OCF Growth snapshot only 10.45%
Asset Growth snapshot only 1.01%
Equity Growth snapshot only 82.09%
Debt Growth snapshot only 20.23%
Shares Change snapshot only 64.75%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y -14.1% -24.1% -16.8% -30.2% -29.2% -24.8% -64.9% -62.7% -60.8% -59.6% -75.3% -83.4% -82.3% -82.1% -81.8%
Revenue 5Y 2.7% -6.3% -48.7% -43.9% -47.8% -47.0% -63.3% -67.8% -66.9% -65.6% -68.5% -65.3% -65.0% -64.95%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 57.3% 57.3% 58.7% 58.7% 58.7% 58.7% 56.4% 56.4% 56.4% 56.4% -4.9% -4.9% -4.9% -4.9% -14.0% -14.0% -14.0% -14.0% 10.6% 10.6% 10.60%
Assets 5Y -0.5% -0.5% 26.8% 26.8% 26.8% 26.8% 30.9% 30.9% 30.9% 30.9% 20.8% 20.8% 20.8% 20.8% 2.7% 2.7% 2.69%
Equity 3Y 66.8% 66.8% 60.3% 60.3% 60.3% 60.3% 59.7% 59.7% 59.7% 59.7% -4.9% -4.9% -4.9% -4.9% -14.7% -14.7% -14.7% -14.7% 6.7% 6.7% 6.67%
Book Value 3Y -52.5% -47.1% -2.1% -3.8% 4.4% 7.3% 7.1% 7.1% 12.8% 35.9% -17.0% -22.1% -20.6% -20.6% -28.7% -28.8% -28.8% -30.1% -15.5% -21.2% -21.23%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.57 0.83 0.30 0.68 0.08 0.18 0.55 0.70 0.83 0.92 0.77 0.94 0.94 0.94 0.81 0.82 0.78 0.89 0.66 0.66 0.661
Earnings Stability 0.56 0.68 0.44 0.50 0.75 0.81 0.58 0.59 0.61 0.81 0.70 0.71 0.84 0.79 0.69 0.58 0.59 0.47 0.34 0.23 0.234
Margin Stability 0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.83 0.99 0.95 0.94 0.94 0.96 0.98 0.97 0.90 0.87 0.97 0.99 0.95 0.92 0.97 1.00 0.996
Earnings Smoothness
ROE Trend 0.43 0.52 -0.15 -0.13 0.06 0.22 -0.10 -0.07 -0.04 -0.02 0.02 0.01 -0.06 -0.10 -0.31 -0.26 -0.23 -0.20 0.22 0.20 0.199
Gross Margin Trend -3.63 -18.14 -14.18 -18.50 -14.20 -7.01 -163.45 97.78 -655.90 -325.07 -377.48 -377.477
FCF Margin Trend -9.31 -21.17 -17.58 -17.11 -12.37 -6.64 -253.38 -1354.34 -2444.16 430.72 98.14 98.140
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.90 0.83 0.81 0.71 0.72 0.77 0.74 0.80 0.88 0.98 0.86 0.79 0.71 0.75 0.84 0.89 0.93 0.79 0.77 0.79 0.790
FCF/OCF 1.20 1.18 1.16 1.11 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 0.790
CapEx/Revenue 2.0% 3.6% 2.8% 2.2% 8.5% 7.2% -1.9% -2.1% -1.8% 30.5% 11.0% 1.0% 0.0% 0.0% 0.0% 0.0% 50.0% 50.0% 26.8% 88.9% 88.89%
CapEx/Depreciation snapshot only 0.302
Accruals Ratio -0.04 -0.09 -0.08 -0.13 -0.12 -0.08 -0.10 -0.08 -0.05 -0.01 -0.06 -0.09 -0.14 -0.12 -0.09 -0.06 -0.03 -0.10 -0.10 -0.09 -0.091
Sloan Accruals snapshot only 0.650
Cash Flow Adequacy snapshot only -2247.969
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.0% 0.0% 0.00%
Net Buyback Yield -49.6% -16.1% -17.0% -11.5% -6.7% -10.9% -6.8% -26.6% -25.3% -10.0% -13.2% -12.1% -15.6% -16.8% -2.0% -11.8% -26.1% -36.1% -47.7% -56.9% -56.86%
Total Shareholder Return -49.6% -16.1% -17.0% -11.5% -6.7% -10.9% -6.8% -26.6% -25.3% -10.0% -13.2% -12.1% -15.6% -16.8% -2.0% -11.8% -26.1% -36.1% -47.7% -56.9% -56.86%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.99 0.99 0.99 0.99 1.00 1.000
Interest Burden (EBT/EBIT) 1.04 1.04 1.14 1.10 1.01 0.99 0.95 0.97 0.94 0.94 0.96 0.96 0.98 1.00 1.00 1.00 1.00 1.01 0.99 0.97 0.974
EBIT Margin -10.57 -23.44 -19.39 -25.76 -27.65 -26.40 1311.28 1113.42 1060.80 -300.05 -216.57 -235.56 -252.35 -1990.58 -4752.50 -4545.60 -4407.75 -4191.75 -2184.12 -2598.28 -2598.278
Asset Turnover 0.04 0.02 0.02 0.02 0.01 0.01 -0.00 -0.00 -0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 1.10 1.10 1.09 1.09 1.09 1.09 1.11 1.11 1.11 1.11 1.10 1.10 1.10 1.10 1.10 1.10 1.10 1.10 1.20 1.20 1.203
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.65 $-2.03 $-2.33 $-2.31 $-2.04 $-1.76 $-1.69 $-1.70 $-1.60 $-1.46 $-1.51 $-1.31 $-1.43 $-1.46 $-1.33 $-1.19 $-1.08 $-0.94 $-0.88 $-0.73 $-0.73
Book Value/Share $5.46 $5.46 $4.77 $4.53 $4.19 $4.04 $3.70 $3.70 $3.66 $3.45 $3.32 $2.74 $2.74 $2.73 $1.73 $1.63 $1.52 $1.38 $2.24 $1.81 $2.28
Tangible Book/Share $5.15 $5.15 $4.48 $4.25 $3.93 $3.79 $3.46 $3.45 $3.41 $3.22 $3.32 $2.74 $2.74 $2.73 $1.73 $1.63 $1.52 $1.38 $2.24 $1.81 $1.81
Revenue/Share $0.15 $0.08 $0.11 $0.08 $0.07 $0.07 $-0.00 $-0.00 $-0.00 $0.01 $0.01 $0.01 $0.01 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-1.78 $-1.98 $-2.17 $-1.83 $-1.48 $-1.37 $-1.25 $-1.37 $-1.41 $-1.43 $-1.30 $-1.03 $-1.01 $-1.10 $-1.12 $-1.06 $-1.00 $-0.75 $-0.67 $-0.58 $-0.58
OCF/Share $-1.48 $-1.68 $-1.88 $-1.64 $-1.47 $-1.36 $-1.25 $-1.37 $-1.41 $-1.43 $-1.30 $-1.03 $-1.01 $-1.10 $-1.12 $-1.06 $-1.00 $-0.75 $-0.67 $-0.58 $-0.58
Cash/Share $5.22 $5.22 $4.56 $4.33 $4.01 $3.86 $3.70 $3.69 $3.65 $3.45 $3.38 $2.79 $2.79 $2.78 $1.85 $1.75 $1.62 $1.47 $2.72 $2.20 $2.66
EBITDA/Share $-1.58 $-1.94 $-2.04 $-2.10 $-2.01 $-1.77 $-1.77 $-1.74 $-1.68 $-1.55 $-1.54 $-1.33 $-1.42 $-1.43 $-1.33 $-1.20 $-1.08 $-0.94 $-0.89 $-0.75 $-0.75
Debt/Share $0.04 $0.04 $0.04 $0.03 $0.03 $0.03 $0.02 $0.02 $0.02 $0.02 $0.01 $0.01 $0.01 $0.01 $0.02 $0.02 $0.02 $0.02 $0.35 $0.29 $0.29
Net Debt/Share $-5.18 $-5.18 $-4.53 $-4.29 $-3.97 $-3.83 $-3.67 $-3.67 $-3.62 $-3.43 $-3.37 $-2.78 $-2.78 $-2.77 $-1.83 $-1.72 $-1.60 $-1.46 $-2.36 $-1.91 $-1.91
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 0.957
Altman Z-Prime snapshot only 3.672
Piotroski F-Score 4 4 2 1 2 2 3 4 3 4 4 4 5 4 1 2 1 2 5 5 5
Beneish M-Score 30.36 120.18 -3.03 0.94 -51.89 14.59 -282.16 -3.92 264.17 1.24 -1168.83 81.63 0.55 -12.28 -0.82 -1.76 0.15
Ohlson O-Score snapshot only -5.941
ROIC (Greenblatt) snapshot only -35.50%
Net-Net WC snapshot only $1.79
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB-
Credit Score 60.96 61.06 61.06 61.83 63.30 63.72 65.60 54.62 49.82 38.57 65.72 65.32 65.62 65.55 65.58 65.67 65.68 65.63 37.58 37.07 37.073
Credit Grade snapshot only 13
Credit Trend snapshot only -28.594
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 29
Sector Credit Rank snapshot only 28

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms